Renbio
UEI: NMYHCDQN7DR3
• CAGE: 7K9J1
Overview
Parent Awardee
Company Description
Observe the efficacy of antibodies therapeutic in reducing the impact of diseases. Get to know our Make Your Own Technology™ and behold the future of medicine.
Name
Renbio
Website
Headquarters
Long Island City, NY
United States
United States
Most Recent Award
Nov. 14, 2024
Calculating
Federal contract and grant recipient
RENBIO, INC.
dba RENBIO INC
(UEI NMYHCDQN7DR3, CAGE 7K9J1)
is headquartered in Long Island City NY.
Its primary registered NAICS is 541714 Research and Development in Biotechnology (except Nanobiotechnology).
The corporation
was founded in December 2013 and
federally registered in
February 2016.
Federal Award Analysis
Renbio federal award history
$-
Contracts
$-
Subcontracts
$-
Grants
$-
Subgrants
$-
Total
No Results
Calculating
Calculating
No Results
Calculating
Calculating
No Results
Calculating
Calculating
| Year | Contracts | Subcontracts | Grants | Subgrants |
|---|
No Results
Calculating
Calculating
No Results
Calculating
Calculating
Federal Registration and Certifications
Legal Name
RENBIO, INC.
DBA
RENBIO INC
UEI
NMYHCDQN7DR3
CAGE Code
7K9J1
SBA Certifications
None
Self Certifications
For Profit Organization
Entity Structure
Corporate Entity (Not Tax Exempt)
Purpose of Registration
Federal Contracts and Assistance
Date Founded
Dec. 10, 2013
Initial Registration
Feb. 10, 2016
Last Registration
May 9, 2025
Registration Activation
May 9, 2025
Registration Expiration
May 8, 2026
Fiscal Year End
December 31
Reported Entity Types
For Profit Organization
State of Incorporation
DE
Country of Incorporation
USA
Employees
<500
Accepts Credit Cards
No
People
Vendor contacts at Renbio
Contract Awards
Renbio prime contract awards
Grant Awards
Renbio direct grants
Subgrant Awards
Renbio subgrant awards
Teaming Partners
Disclosed awardee sub and prime contract and grant relationships
Renbio